Contact
searchSearch
HMP Global
Login
Conference Coverage
Real-World Evidence in Oncology: Opportunities, Challenges, and Clinical Impact
09/10/2025
Grace Taylor, MS, MA
In this CPC+CBEx session, experts debate how real-world evidence can complement clinical trials, accelerate regulatory approvals, and reshape patient care.
In this CPC+CBEx session, experts debate how real-world evidence can complement clinical trials, accelerate regulatory approvals, and reshape patient care.
In this CPC+CBEx session,...
09/10/2025
Journal of Clinical Pathways
Conference Coverage
Building a Transparent Framework for Predictable Cost of Care in Oncology Pathways
09/10/2025
Hannah Musick
The Predictable Cost of Care initiative is creating a transparent, standardized model to quantify the true, incremental costs of cancer therapies—enabling more informed, equitable, and efficient decision-making across pathways, payers, and...
The Predictable Cost of Care initiative is creating a transparent, standardized model to quantify the true, incremental costs of cancer therapies—enabling more informed, equitable, and efficient decision-making across pathways, payers, and...
The Predictable Cost of Care...
09/10/2025
Journal of Clinical Pathways
Conference Coverage
Reviewing a Decade of Oncology Pathways: Standardization, Gaps, and the Road to Real-Time Intelligence
09/09/2025
Hannah Musick
A decade after the American Society of Clinical Oncology’s (ASCO’s) original guidance, oncology pathways are maturing into powerful tools for standardizing care, but gaps in disease coverage, workflow integration, and real-time adaptability...
A decade after the American Society of Clinical Oncology’s (ASCO’s) original guidance, oncology pathways are maturing into powerful tools for standardizing care, but gaps in disease coverage, workflow integration, and real-time adaptability...
A decade after the American...
09/09/2025
Journal of Clinical Pathways
Conference Coverage
How AI is Reshaping Clinical Practice, Governance, and Patient Trust
09/09/2025
Grace Taylor, MS, MA
From streamlining documentation to reshaping prior authorization, a panel of experts reveal how artificial intelligence (AI) is changing the realities of cancer care—and the challenges that come with it.
From streamlining documentation to reshaping prior authorization, a panel of experts reveal how artificial intelligence (AI) is changing the realities of cancer care—and the challenges that come with it.
From streamlining documentation...
09/09/2025
Journal of Clinical Pathways
Conference Coverage
From Dispensing to Decision-Making: How Pharmacists Are Redefining Leadership in Oncology Care
09/08/2025
Grace Taylor, MS, MA
This session highlights how pharmacists are stepping into pivotal leadership roles, balancing science, business, and patient care to navigate the increasingly complex oncology treatment landscape.
This session highlights how pharmacists are stepping into pivotal leadership roles, balancing science, business, and patient care to navigate the increasingly complex oncology treatment landscape.
This session highlights how...
09/08/2025
Journal of Clinical Pathways
Conference Coverage
Theranostics: Clinical Promise, Operational Hurdles, and the Road Ahead
09/08/2025
Hannah Musick
Theranostics is rapidly emerging as a transformative, fifth pillar of cancer care—combining precision imaging and targeted radiopharmaceutical therapy—but its widespread adoption hinges on overcoming operational, financial, and infrastructure...
Theranostics is rapidly emerging as a transformative, fifth pillar of cancer care—combining precision imaging and targeted radiopharmaceutical therapy—but its widespread adoption hinges on overcoming operational, financial, and infrastructure...
Theranostics is rapidly emerging...
09/08/2025
Journal of Clinical Pathways
Conference Coverage
Scaling Bispecifics and CAR T-Cell Therapy in Community Oncology: From Promise to Practice
09/08/2025
Hannah Musick
A panel of oncology leaders urged community practices to take immediate, systematized steps to adopt bispecifics and CAR T-cell therapies—highlighting that without local access, the promise of these innovations may never reach the patients...
A panel of oncology leaders urged community practices to take immediate, systematized steps to adopt bispecifics and CAR T-cell therapies—highlighting that without local access, the promise of these innovations may never reach the patients...
A panel of oncology leaders...
09/08/2025
Journal of Clinical Pathways
News
Policy and Payment Shifts on the Horizon: Navigating Uncertainty in Cancer Care
09/08/2025
Hannah Musick
A sweeping policy and payment update at the conference revealed mounting pressure across Medicaid, Medicare, and employer markets—posing new risks and strategic imperatives for oncology providers navigating a rapidly shifting health care...
A sweeping policy and payment update at the conference revealed mounting pressure across Medicaid, Medicare, and employer markets—posing new risks and strategic imperatives for oncology providers navigating a rapidly shifting health care...
A sweeping policy and payment...
09/08/2025
Journal of Clinical Pathways
Conference Coverage
Practical Insights for Embedding Whole-Person Care into Clinical Pathways
09/08/2025
Juliet Gallagher
A session at CPC+CBEx 2025 highlighted how structured triage, real-time care coordination, and non-clinical staff training can transform symptom management and reduce unnecessary acute care utilization in oncology.
A session at CPC+CBEx 2025 highlighted how structured triage, real-time care coordination, and non-clinical staff training can transform symptom management and reduce unnecessary acute care utilization in oncology.
A session at CPC+CBEx 2025...
09/08/2025
Journal of Clinical Pathways
Conference Coverage
Reinventing Health Care: Tom Koulopoulos on AI, Behavioral Shifts, and the Human Future of Medicine
09/08/2025
Grace Taylor, MS, MA
In his keynote address, Thomas Koulopoulos argues that the true future of health care lies not in technology alone but in reimagining human behaviors to create a seamless, patient-driven system empowered by artificial intelligence (AI).
In his keynote address, Thomas Koulopoulos argues that the true future of health care lies not in technology alone but in reimagining human behaviors to create a seamless, patient-driven system empowered by artificial intelligence (AI).
In his keynote address, Thomas...
09/08/2025
Journal of Clinical Pathways
Blog
CPC+CBEx 2025 Abstracts: Business Models, Breakthrough Tools, and Data-Driven Decisions Driving the Future of Cancer Care
08/27/2025
The 2025 Clinical Pathways Congress + Cancer Care Business Exchange (CPC+CBEx), to be held September 5-6 in Boston, will confront these challenges head-on through 13 powerful abstracts that demonstrate what it takes to translate evidence into...
The 2025 Clinical Pathways Congress + Cancer Care Business Exchange (CPC+CBEx), to be held September 5-6 in Boston, will confront these challenges head-on through 13 powerful abstracts that demonstrate what it takes to translate evidence into...
The 2025 Clinical Pathways...
08/27/2025
Journal of Clinical Pathways
Abstracts
Enhancing Oncology Documentation and Diagnosis Capture With Integrated AI Scribe in Electronic Health Record
08/25/2025
Eileen Campetti, PA-C, MS; Saranga Arora, MS, MBA; Helena Hay; Jennifer Siggia, RN, MSN; Stephen Speicher, MD, MS
In a pre-post study across 258 oncology clinics, integration of DeepScribe’s oncology-specific artificial intelligence (AI) scribe into the Flatiron Health OncoEMR electronic health record (EHR) system resulted in high adoption (98%),...
In a pre-post study across 258 oncology clinics, integration of DeepScribe’s oncology-specific artificial intelligence (AI) scribe into the Flatiron Health OncoEMR electronic health record (EHR) system resulted in high adoption (98%),...
In a pre-post study across 258...
08/25/2025
Journal of Clinical Pathways
Abstracts
Provision of Comparative Clinical Evidence to Support Pathway Decision-Making
08/25/2025
Aimee Ginsburg, PharmD, BCPS; Daniel Rubin, PharmD, BCOP; Victoria Handy, PharmD, BCOP; Steven Gilmore, PharmD, BCOP; Stephen Clark, PharmD, BCOP
Initially developed to support the Pathways Task Force (PTF) within the Value Pathways powered by the National Comprehensive Cancer Network (NCCN), embedded evidence tables summarizing clinical trial data—including patient-reported...
Initially developed to support the Pathways Task Force (PTF) within the Value Pathways powered by the National Comprehensive Cancer Network (NCCN), embedded evidence tables summarizing clinical trial data—including patient-reported...
Initially developed to support...
08/25/2025
Journal of Clinical Pathways
Abstracts
Assessing EHR-to-EDC Data Transfer Solutions
08/25/2025
Kristy L. Johnson; Jeffrey Minehart; Molly Lieber
In a pilot study at UChicago Medicine, Flatiron Clinical Pipe—a study-agnostic electronic health record (EHR)–to–electronic data capture (EDC) integration tool—automated the transfer of 4700 structured data points across two gastrointestinal...
In a pilot study at UChicago Medicine, Flatiron Clinical Pipe—a study-agnostic electronic health record (EHR)–to–electronic data capture (EDC) integration tool—automated the transfer of 4700 structured data points across two gastrointestinal...
In a pilot study at UChicago...
08/25/2025
Journal of Clinical Pathways
Abstracts
Green Light, Red Flags: A New Framework for Evaluating Oncology Accelerated Approvals
08/25/2025
Sang Chau, PharmD, BCOP; Justin R. Tse, PharmD, BCOP; Amy VanGalder, PharmD, BCOP; Terra Wonsettler, PharmD, MBA; Andrew Hertler, MD, FACP
To improve transparency and consistency in evaluating oncology therapies granted US Food and Drug Administration (FDA) Accelerated Approval (AA), Evolent developed the Clinical Benefit Index (CBI)—a framework combining the European Society...
To improve transparency and consistency in evaluating oncology therapies granted US Food and Drug Administration (FDA) Accelerated Approval (AA), Evolent developed the Clinical Benefit Index (CBI)—a framework combining the European Society...
To improve transparency and...
08/25/2025
Journal of Clinical Pathways
Abstracts
Streamlining Clinical Decision Support Through Integrated Education
08/25/2025
Victoria Handy, PharmD, BCOP; Daniel Rubin, PharmD, BCOP; Steven Gilmore, PharmD, BCOP; Stephen Clark, PharmD, BCOP; Aimee Ginsburg, PharmD, BCPS
To improve workflow efficiency and clinical decision-making, the Clear Value Plus (CVP) clinical decision support (CDS) tool integrated Launch N’ Learn—an embedded feature providing point-of-care access to staging criteria and guideline-based...
To improve workflow efficiency and clinical decision-making, the Clear Value Plus (CVP) clinical decision support (CDS) tool integrated Launch N’ Learn—an embedded feature providing point-of-care access to staging criteria and guideline-based...
To improve workflow efficiency...
08/25/2025
Journal of Clinical Pathways
Abstracts
Ensuring Access to Care: Using Tax-Exempt and Taxable Bond Funding for Consolidation of Outpatient Specialties
08/25/2025
Greg Merrill
Faced with rising operational costs and declining reimbursement, Radiation Business Solutions created a tax-exempt, bond-funded not-for-profit model to consolidate four independent for-profit cancer centers in Alaska, demonstrating that...
Faced with rising operational costs and declining reimbursement, Radiation Business Solutions created a tax-exempt, bond-funded not-for-profit model to consolidate four independent for-profit cancer centers in Alaska, demonstrating that...
Faced with rising operational...
08/25/2025
Journal of Clinical Pathways
Abstracts
From Approval to Action: Evaluating Review Timelines for Oncology Therapies in Value Pathways
08/25/2025
Victoria Handy, PharmD, BCOP; Daniel Rubin, PharmD, BCOP; Steven Gilmore, PharmD, BCOP; Stephen Clark, PharmD, BCOP; Aimee Ginsburg, PharmD, BCPS
A retrospective analysis of 84 oncology drug approvals from January 2024 to June 2025 demonstrated that the US Oncology Network’s Pathways Task Force (PTF) conducted timely reviews—averaging 54 days post–US Food and Drug Administration (FDA)...
A retrospective analysis of 84 oncology drug approvals from January 2024 to June 2025 demonstrated that the US Oncology Network’s Pathways Task Force (PTF) conducted timely reviews—averaging 54 days post–US Food and Drug Administration (FDA)...
A retrospective analysis of 84...
08/25/2025
Journal of Clinical Pathways
Abstracts
Decision Support Documentation for Targeted Therapy Eligibility in Breast Cancer
08/25/2025
Daniel Rubin, PharmD, BCOP; Victoria Handy, PharmD, BCOP; Steven Gilmore, PharmD, BCOP; Stephen Clark, PharmD, BCOP; Aimee Ginsburg, PharmD, BCPS
Re-prompting providers within the Clear Value Plus clinical decision support system significantly improved documentation of AKT1, PTEN, and PIK3CA biomarkers and increased the use of precision therapies for hormone receptor–positive,...
Re-prompting providers within the Clear Value Plus clinical decision support system significantly improved documentation of AKT1, PTEN, and PIK3CA biomarkers and increased the use of precision therapies for hormone receptor–positive,...
Re-prompting providers within...
08/25/2025
Journal of Clinical Pathways
Abstracts
Modification of PARP Inhibitor Use in mCRPC With Co-Occurring BRCA1/2 Mutations and MSI-High Status
08/25/2025
Steven Gilmore, PharmD, BCOP; Aimee Ginsburg, PharmD, BCPS; Victoria Handy, PharmD, BCOP; Daniel Rubin, PharmD, BCOP; Stephen Clark, PharmD, BCOP; Dhaval Shah, MBBS
Following an update to the US Oncology Network’s Prostate Cancer Pathway reflecting evidence that BRCA1/2 mutations in microsatellite instability–high (MSI-H) tumors are typically monoallelic and not associated with PARP inhibitor...
Following an update to the US Oncology Network’s Prostate Cancer Pathway reflecting evidence that BRCA1/2 mutations in microsatellite instability–high (MSI-H) tumors are typically monoallelic and not associated with PARP inhibitor...
Following an update to the US...
08/25/2025
Journal of Clinical Pathways
Abstracts
From Fragmented to Integrated: A Roadmap to Equity for Psychosocial Support in Rural and Underserved Cancer Programs
08/25/2025
Jerlinda Ross, MD, MS, MBA; James Emery, PhD
An environmental scan revealed that integrating psychosocial care into oncology programs—especially in underserved and rural communities—is hindered by systemic and structural barriers, prompting the development of a strategic four-part...
An environmental scan revealed that integrating psychosocial care into oncology programs—especially in underserved and rural communities—is hindered by systemic and structural barriers, prompting the development of a strategic four-part...
An environmental scan revealed...
08/25/2025
Journal of Clinical Pathways
Abstracts
Efficacy, Safety, and End-of-Treatment Mutational Results From the 5-Year Follow-Up of the Phase 2 OPTIC Study in Patients With Chronic-Phase Chronic Myeloid Leukemia
08/25/2025
Jorge Cortes, MD; Michael Deininger, MD, PhD; Jane Apperley, MD; Andreas Hochhaus, MD; Hugues de Lavallade, MD, PhD; Jeffrey Lipton, MD, PhD; Elza Lomaia, MD, PhD; James McCloskey, MD; Lori Maness, MD; Michael Mauro, MD; Beatriz Moiraghi, MD; Carolina Pavlovsky, MD; Gianantonio Rosti, MD; Philippe Rousselot, MD, PhD; Maria Undurraga Sutton, MD; Bo Chao, MS; Alexander Vorog, MD; Tammie Yeh, PhD; Niti Patel, PhD; Hagop Kantarjian, MD
The 5-year results of the OPTIC study demonstrate that a response-based dosing strategy of ponatinib—starting at 45 mg daily and reducing to 15 mg upon achieving major molecular response—provides sustained efficacy and manageable safety in...
The 5-year results of the OPTIC study demonstrate that a response-based dosing strategy of ponatinib—starting at 45 mg daily and reducing to 15 mg upon achieving major molecular response—provides sustained efficacy and manageable safety in...
The 5-year results of the OPTIC...
08/25/2025
Journal of Clinical Pathways
Abstracts
Pharmacist-Driven Outcomes for Patients on Oral Oncology Medications: Clinical Impact of an Integrated Specialty Pharmacy Model
08/25/2025
Kishen Patel, PharmD; Martha Stutsky, PharmD; Y. Caleb Chun, MA; Shreevidya Periyasamy, MS; Chelsey Lindner, PharmD, BCOP
In a retrospective evaluation of 6668 patients receiving oral oncology medications through an academic health system specialty pharmacy (HSSP), pharmacist-led interventions—primarily targeting drug safety and adherence—were associated with...
In a retrospective evaluation of 6668 patients receiving oral oncology medications through an academic health system specialty pharmacy (HSSP), pharmacist-led interventions—primarily targeting drug safety and adherence—were associated with...
In a retrospective evaluation of...
08/25/2025
Journal of Clinical Pathways
Abstracts
Cost-Effectiveness of BTKis in Medicare Patients With CLL in First-Line and Relapsed/Refractory Settings
08/25/2025
Bhavini Srivastava, MSc; Huimin Li, MA; Pam Martin, PhD; James Gahn, BS; Shaffee Bacchus, PharmD; Erin Franceschini, MS; Kavita Sail, PhD
Using a semi-Markov model from a US Medicare perspective, ibrutinib priced at the Centers for Medicare & Medicaid Services–negotiated maximum fair price (MFP) was found to be cost-effective compared with acalabrutinib and zanubrutinib at...
Using a semi-Markov model from a US Medicare perspective, ibrutinib priced at the Centers for Medicare & Medicaid Services–negotiated maximum fair price (MFP) was found to be cost-effective compared with acalabrutinib and zanubrutinib at...
Using a semi-Markov model from a...
08/25/2025
Journal of Clinical Pathways
CPC+CBEx SESSION TEASERS
Predictable Cost of Care Working Group Phase 2 Update: Building the Model
08/15/2025
Carole Tremonti, RN, MBA
Decision support for oncology treatment has been at the forefront of oncology decision-making for over 20 years, yet the methods in which we evaluate and select regimens for a pathway has remained the same. Within our community, we have all...
Decision support for oncology treatment has been at the forefront of oncology decision-making for over 20 years, yet the methods in which we evaluate and select regimens for a pathway has remained the same. Within our community, we have all...
Decision support for oncology...
08/15/2025
Journal of Clinical Pathways
CPC+CBEx SESSION TEASERS
Bridging the Care Gaps: Patient Support and Extended Cross-Continuum Care Management Outside the Clinic Walls
08/15/2025
Dan Nardi
Learn how a thoughtfully integrated combination of clinical teams and scalable, [artificial intelligence] technology can enable around-the-clock patient support, reinforce adherence to evidence-based clinical pathways, and extend high-quality...
Learn how a thoughtfully integrated combination of clinical teams and scalable, [artificial intelligence] technology can enable around-the-clock patient support, reinforce adherence to evidence-based clinical pathways, and extend high-quality...
Learn how a thoughtfully...
08/15/2025
Journal of Clinical Pathways
Interview
CPC+CBEx 2025 Is the Meeting Oncology Leaders Can’t Afford to Miss: A Q&A with Aimee Ginsburg Chesnick
08/04/2025
Aimee Ginsburg, PharmD, BCPS
As the pace of therapeutic advancement accelerates, the need to thoughtfully integrate novel treatments into real-world care settings is increasingly critical. In this Q&A, Steering Committee member and conference speaker Aimee Ginsburg...
As the pace of therapeutic advancement accelerates, the need to thoughtfully integrate novel treatments into real-world care settings is increasingly critical. In this Q&A, Steering Committee member and conference speaker Aimee Ginsburg...
As the pace of therapeutic...
08/04/2025
Journal of Clinical Pathways
Videos
Driving Innovation in Cancer Care: The Future of Value-Based Care in Oncology
12/04/2024
Gordon Kuntz
In this interview, Gordon Kuntz discusses the Delphi Method, a Predictable Cost of Care Model developed by the Predictable Cost of Care Working Group that enhances oncology market access strategies by standardizing and broadening the economic...
In this interview, Gordon Kuntz discusses the Delphi Method, a Predictable Cost of Care Model developed by the Predictable Cost of Care Working Group that enhances oncology market access strategies by standardizing and broadening the economic...
In this interview, Gordon Kuntz...
12/04/2024
Journal of Clinical Pathways
Videos
Building Consensus for Predictable Cancer Care Costs: Applying the Delphi Method to Multidisciplinary Stakeholder Collaboration
12/02/2024
Carole Tremonti, RN, MBA
In this interview, Carole Tremonti, RN, MBA, discusses the critical role of clinical pathways in equitable cancer care, the application of the Delphi Method by the Predictable Cost of Care Working Group to foster multidisciplinary...
In this interview, Carole Tremonti, RN, MBA, discusses the critical role of clinical pathways in equitable cancer care, the application of the Delphi Method by the Predictable Cost of Care Working Group to foster multidisciplinary...
In this interview, Carole...
12/02/2024
Journal of Clinical Pathways
Videos
The Evolving Role of Pharmacists in Custom Pathway Implementation
11/25/2024
Rebecca Maniago, PharmD, BCOP
In this interview, Rebecca Maniago, PharmD, discusses the complexities of implementing custom clinical pathways, emphasizing the need for clear goals, robust resources, and ongoing updates, while highlighting the pivotal role of pharmacists...
In this interview, Rebecca Maniago, PharmD, discusses the complexities of implementing custom clinical pathways, emphasizing the need for clear goals, robust resources, and ongoing updates, while highlighting the pivotal role of pharmacists...
In this interview, Rebecca...
11/25/2024
Journal of Clinical Pathways
Kolodziej Headshot
Videos
Understanding the Impact of Venture Capital and Private Equity in Oncology
11/18/2024
Michael Kolodziej, MD
Michael Kolodziej, MD, discusses the growing influence of venture capital and private equity in oncology care, highlighting the potential for these trends to reshape costs, partnerships, and innovation in the oncology landscape.
Michael Kolodziej, MD, discusses the growing influence of venture capital and private equity in oncology care, highlighting the potential for these trends to reshape costs, partnerships, and innovation in the oncology landscape.
Michael Kolodziej, MD, discusses...
11/18/2024
Journal of Clinical Pathways
Videos
Evolving Oncology Pathways, CLL Treatment Advances, and the Role of Multidisciplinary Care Teams
11/12/2024
Shaffee Bacchus, PharmD
Shaffee Bacchus, PharmD, discusses the evolution of oncology pathways, advancements in chronic lymphocytic leukemia (CLL) treatment, and the importance of multidisciplinary care teams in addressing comorbidities and enhancing patient quality...
Shaffee Bacchus, PharmD, discusses the evolution of oncology pathways, advancements in chronic lymphocytic leukemia (CLL) treatment, and the importance of multidisciplinary care teams in addressing comorbidities and enhancing patient quality...
Shaffee Bacchus, PharmD,...
11/12/2024
Journal of Clinical Pathways
Conference Coverage
Oncology Pathways Research: Challenges, Adoption, and Future Trends
11/08/2024
Cindy Chen, MBA
In an exclusive interview with the Journal of Clinical Pathways, Cindy Chen, Head of Research at HMP Market Access Insights, shares insights into the challenges, adoption, and future trends of oncology pathways research. Her discussion draws...
In an exclusive interview with the Journal of Clinical Pathways, Cindy Chen, Head of Research at HMP Market Access Insights, shares insights into the challenges, adoption, and future trends of oncology pathways research. Her discussion draws...
In an exclusive interview with...
11/08/2024
Journal of Clinical Pathways
Videos
Navigating Multidisciplinary Care: Insights on Oncology Practice Integration and Pharmaceutical Partnerships
11/04/2024
John Hennessy, MBA
John Hennessy, Principal at Valuate Health Consultancy, highlights the importance of multidisciplinary collaboration in oncology care to improve patient outcomes.
John Hennessy, Principal at Valuate Health Consultancy, highlights the importance of multidisciplinary collaboration in oncology care to improve patient outcomes.
John Hennessy, Principal at...
11/04/2024
Journal of Clinical Pathways
Videos
Custom Pathways in Oncology: Innovations, Stakeholder Collaboration, and Value-Based Care
11/01/2024
James Hamrick, MD, MPH
James Hamrick, MD, MPH, Vice President of Clinical Oncology at Flatiron Health, highlights the importance of custom oncology pathways in enabling real-time updates for oncologists, fostering collaborative implementation teams, and supporting...
James Hamrick, MD, MPH, Vice President of Clinical Oncology at Flatiron Health, highlights the importance of custom oncology pathways in enabling real-time updates for oncologists, fostering collaborative implementation teams, and supporting...
James Hamrick, MD, MPH, Vice...
11/01/2024
Journal of Clinical Pathways
News
CPC + CBEx 2024: Influence and Impact of Oncology Pathways
09/25/2024
Grace Taylor, MS, MA
HMP Market Access Insights researchers shared their findings on the impact of pathway programs on treatment selections at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange.
HMP Market Access Insights researchers shared their findings on the impact of pathway programs on treatment selections at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange.
HMP Market Access Insights...
09/25/2024
Journal of Clinical Pathways
Conference Coverage
CPC + CBEx 2024: Integration of Medical Oncology and Surgical Specialties
09/19/2024
Grace Taylor, MS, MA
Presenters at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange shared how their institutions integrate medical oncology and surgical specialties for genitourinary cancers and some of the challenges they face both clinically...
Presenters at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange shared how their institutions integrate medical oncology and surgical specialties for genitourinary cancers and some of the challenges they face both clinically...
Presenters at the 2024 Clinical...
09/19/2024
Journal of Clinical Pathways
Conference Coverage
CPC + CBEx 2024: Pathways for Social Needs Assessment and Care
09/18/2024
In a session at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange, experts went over the importance of social needs assessment and care in oncology and provided an example of pathways that help in providing these services to...
In a session at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange, experts went over the importance of social needs assessment and care in oncology and provided an example of pathways that help in providing these services to...
In a session at the 2024...
09/18/2024
Journal of Clinical Pathways
Conference Coverage
CPC + CBEx 2024: Managing Clinical & Financial Risk in Oncology
09/13/2024
Grace Taylor, MS, MA
A group of oncology practice innovators and care platform disruptors spoke about managing clinical and financial risk in oncology as part of a session at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange.
A group of oncology practice innovators and care platform disruptors spoke about managing clinical and financial risk in oncology as part of a session at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange.
A group of oncology practice...
09/13/2024
Journal of Clinical Pathways
Conference Coverage
CPC + CBEx 2024: Strategies for Patient Navigation Services
09/12/2024
Grace Taylor, MS, MA
Learn about different implementation strategies for patient navigation presented at a session at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange.
Learn about different implementation strategies for patient navigation presented at a session at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange.
Learn about different...
09/12/2024
Journal of Clinical Pathways
Conference Coverage
CPC + CBEx 2024: CancerX Updates
09/11/2024
Grace Taylor, MS, MA
Learn about the latest initiatives from CancerX presented at a session at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange.
Learn about the latest initiatives from CancerX presented at a session at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange.
Learn about the latest...
09/11/2024
Journal of Clinical Pathways
News
Study Examines Impact of Vial Sizes on Drug Waste of Multiple Myeloma Treatment
09/06/2024
Grace Taylor, MS, MA
Researchers looked at the impact of vial sizes on drug waste and cost when using bortezomib and carfilzomib to treat patients with multiple myeloma.
Researchers looked at the impact of vial sizes on drug waste and cost when using bortezomib and carfilzomib to treat patients with multiple myeloma.
Researchers looked at the impact...
09/06/2024
Journal of Clinical Pathways
Abstracts
Clinical Benefits and Commonly Reported Adverse Events and Their Associated Costs in Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors in First-Line and Relapsed/Refractory Settings
08/23/2024
Ibrutinib, acalabrutinib, and zanubrutinib are Bruton tyrosine kinase inhibitors (BTKis) approved for treatment of chronic lymphocytic leukemia (CLL). In this study, researchers used data from package inserts, clinical trials, and real-world...
Ibrutinib, acalabrutinib, and zanubrutinib are Bruton tyrosine kinase inhibitors (BTKis) approved for treatment of chronic lymphocytic leukemia (CLL). In this study, researchers used data from package inserts, clinical trials, and real-world...
Ibrutinib, acalabrutinib, and...
08/23/2024
Journal of Clinical Pathways
Abstracts
The Impact in Quality of Life of Adverse Events With Systemic Therapies for Metastatic Colorectal Cancer Previously Treated With Standard Therapies and Biologics in the United States
08/23/2024
Systemic therapies for metastatic colorectal cancer (mCRC) have distinct safety and tolerability profiles. Adverse events (AEs) may occur and compromise the course of treatment, increase health care utilization and costs, and worsen patients’...
Systemic therapies for metastatic colorectal cancer (mCRC) have distinct safety and tolerability profiles. Adverse events (AEs) may occur and compromise the course of treatment, increase health care utilization and costs, and worsen patients’...
Systemic therapies for...
08/23/2024
Journal of Clinical Pathways
Abstracts
The Economic Impact of Vial Sizes on Drug Waste of Bortezomib and Carfilzomib in Multiple Myeloma: The US Oncology Network Study
08/23/2024
Drug waste poses a significant challenge in the field of health care, resulting in increased costs and environmental concerns. Using administrative claims data for Medicare patients from 15 practices in The US Oncology Network, researchers...
Drug waste poses a significant challenge in the field of health care, resulting in increased costs and environmental concerns. Using administrative claims data for Medicare patients from 15 practices in The US Oncology Network, researchers...
Drug waste poses a significant...
08/23/2024
Journal of Clinical Pathways
Abstracts
Ready or Not: Assessment of Readiness for Oncology Value-Based Care Program Participation
08/23/2024
Conducting a thorough and systemic evaluation of practice readiness for value-based care (VBC) programs empowers practices to make informed decisions about VBC model participation. VBC programs like the Enhancing Oncology Model (EOM) offers...
Conducting a thorough and systemic evaluation of practice readiness for value-based care (VBC) programs empowers practices to make informed decisions about VBC model participation. VBC programs like the Enhancing Oncology Model (EOM) offers...
Conducting a thorough and...
08/23/2024
Journal of Clinical Pathways
Abstracts
Beyond the Diagnosis: Exploring the Multifaceted Distress Profile of Patients With Cancer
08/23/2024
To fully understand and rectify impediments to optimal patient outcomes and experiences for patients with cancer, researchers reviewed health-related social needs (HRSN) to fully understand how to provide support to affected patients....
To fully understand and rectify impediments to optimal patient outcomes and experiences for patients with cancer, researchers reviewed health-related social needs (HRSN) to fully understand how to provide support to affected patients....
To fully understand and rectify...
08/23/2024
Journal of Clinical Pathways
Abstracts
A Pilot Program of Automated Patient Identification for Survivorship Resources Using Clinical Oncology Pathways
08/23/2024
Manual electronic health records (EHR) can help bridge the gap between patients with cancer and survivorship resources. In this study, researchers conducted a pilot using a web-based clinical pathways decision-support platform to provide...
Manual electronic health records (EHR) can help bridge the gap between patients with cancer and survivorship resources. In this study, researchers conducted a pilot using a web-based clinical pathways decision-support platform to provide...
Manual electronic health records...
08/23/2024
Journal of Clinical Pathways
Abstracts
Claims Payment Status for On-Pathway Navigations Across an Academic Cancer Center and its Network
08/23/2024
Delays in cancer treatment authorization often impede optimal patient care. In this retrospective assessment of payment rates, the Dana-Farber Cancer Institute explores payer approval decisions for on-pathway treatments.
Delays in cancer treatment authorization often impede optimal patient care. In this retrospective assessment of payment rates, the Dana-Farber Cancer Institute explores payer approval decisions for on-pathway treatments.
Delays in cancer treatment...
08/23/2024
Journal of Clinical Pathways
Abstracts
Impact of an EHR-Embedded Clinical Decision Support (CDS) Tool on Guideline Adoption: A Retrospective Analysis of Clinician Adaptation to Treatment Intensification in Prostate Cancer
08/23/2024
According to research published in the Journal of Clinical Oncology, clinical decision support (CDS) tools can foster an accelerated uptake of new therapies compared to non-users. In this study, researchers used a CDS tool called Flatiron...
According to research published in the Journal of Clinical Oncology, clinical decision support (CDS) tools can foster an accelerated uptake of new therapies compared to non-users. In this study, researchers used a CDS tool called Flatiron...
According to research published...
08/23/2024
Journal of Clinical Pathways
Abstracts
Building an Episode of Care to Reduce Time to Treatment
08/23/2024
When previously identifying causes of delay in cancer treatment, existing workflows often did not provide consistent timelines estimated for providers to diagnose and treat patients. To reduce time to treatment, researchers employed a pilot...
When previously identifying causes of delay in cancer treatment, existing workflows often did not provide consistent timelines estimated for providers to diagnose and treat patients. To reduce time to treatment, researchers employed a pilot...
When previously identifying...
08/23/2024
Journal of Clinical Pathways
Abstracts
Iris: Using a Telehealth Platform to Provide Virtual Supportive Care for Patients in Oncology
08/23/2024
Telehealth technologies are emerging as transformative tools in health care. Implementing telehealth strategies allows providers to bridge the gap between access to support services, improving patient outcomes and overall experience. In a...
Telehealth technologies are emerging as transformative tools in health care. Implementing telehealth strategies allows providers to bridge the gap between access to support services, improving patient outcomes and overall experience. In a...
Telehealth technologies are...
08/23/2024
Journal of Clinical Pathways
Ira Klein, MD.
Videos
AI in Health Care: Foundations, Myths, and Practical Applications
02/07/2024
Ira Klein, MD, MBA, FACP
Ira Klein, MD, MBA, vice president of medical affairs for Tempus Labs, provides insight into the future of AI in health care and how it will help cut down on mundane tasks and increase oncologists’ efficiency.
Ira Klein, MD, MBA, vice president of medical affairs for Tempus Labs, provides insight into the future of AI in health care and how it will help cut down on mundane tasks and increase oncologists’ efficiency.
Ira Klein, MD, MBA, vice...
02/07/2024
Journal of Clinical Pathways
David F. Lobach, MD, PhD, MS
Videos
How Patient-Centered Cancer Symptom Management Can Help Improve Patient Outcomes
01/25/2024
David F. Lobach, MD, PhD
David F. Lobach, MD, PhD, vice president of Health Informatics Research for Elimu Informatics, provides an overview of the Cancer Symptom Management system as a clinical decision support tool for a patient-centered treatment approach.
David F. Lobach, MD, PhD, vice president of Health Informatics Research for Elimu Informatics, provides an overview of the Cancer Symptom Management system as a clinical decision support tool for a patient-centered treatment approach.
David F. Lobach, MD, PhD, vice...
01/25/2024
Journal of Clinical Pathways
Harlan Levine, MD
Videos
Expanding Access to Care Through Academic-Community Cancer Care Collaboration
01/23/2024
Harlan Levine, MD
Harlan Levine, MD, highlights the benefits of the collaboration between community cancer centers and academic medical centers, including allowing for more access to patient care.
Harlan Levine, MD, highlights the benefits of the collaboration between community cancer centers and academic medical centers, including allowing for more access to patient care.
Harlan Levine, MD, highlights...
01/23/2024
Journal of Clinical Pathways
Frederick M. Schnell, MD
Videos
Trends in the Rising Costs of Care Among Self-Insured Employers
01/11/2024
Frederick M. Schnell, MD, FACP
Frederick M. Schnell, MD, FACP, discusses the rising costs of cancer care for self-insured employers and how they can partner with cancer centers to continue to provide high-value care despite the cost increases.
Frederick M. Schnell, MD, FACP, discusses the rising costs of cancer care for self-insured employers and how they can partner with cancer centers to continue to provide high-value care despite the cost increases.
Frederick M. Schnell, MD, FACP,...
01/11/2024
Journal of Clinical Pathways
Conference Highlights
Key Highlights From CPC+CBEx 2023
12/14/2023
The Clinical Pathways Congress + Cancer Care Business Exchange annual meeting was held in Boston, October 6-8, 2023. Topics included the role of AI in oncology, challenges in clinical trial recruitment, and more.
The Clinical Pathways Congress + Cancer Care Business Exchange annual meeting was held in Boston, October 6-8, 2023. Topics included the role of AI in oncology, challenges in clinical trial recruitment, and more.
The Clinical Pathways Congress +...
12/14/2023
Journal of Clinical Pathways
Ronald Barkley Headshot
Videos
Players and Disruptors in Health Care Industry Consolidation
12/05/2023
Ronald Barkley, MS, JD
Ronald Barkley, MS, JD, Cancer Center Business Development Group, provides an overview of the current consolidation of the health care industry and the major players and disruptors leading this transformation.
Ronald Barkley, MS, JD, Cancer Center Business Development Group, provides an overview of the current consolidation of the health care industry and the major players and disruptors leading this transformation.
Ronald Barkley, MS, JD, Cancer...
12/05/2023
Cancer Care Business Exchange
Nicolas Ferreyros, Community Oncology Alliance.
Videos
Updates from Washington Impacting Community Oncology Practices
11/15/2023
Nicolas Ferreyros
In this interview, Nicolas Ferreyros, managing director, Community Oncology Alliance, summarizes some of the latest developments from Washington that are impacting cancer care and providers in community oncology.
In this interview, Nicolas Ferreyros, managing director, Community Oncology Alliance, summarizes some of the latest developments from Washington that are impacting cancer care and providers in community oncology.
In this interview, Nicolas...
11/15/2023
Cancer Care Business Exchange
David Eagleton
Videos
What the Growth of Medicare Advantage Means for Value-Based Care in Community Oncology
11/06/2023
David Eagleton
David Eagleton, Oncology Care Partners, shares his thoughts on the growth of Medicare Advantage and its impact on community oncology practices in providing value-based care.
David Eagleton, Oncology Care Partners, shares his thoughts on the growth of Medicare Advantage and its impact on community oncology practices in providing value-based care.
David Eagleton, Oncology Care...
11/06/2023
Journal of Clinical Pathways
Sibel Blau, MD
Videos
How Technologies and New Models Are Changing Clinical Research
11/02/2023
Sibel Blau, MD
Sibel Blau, MD, provides insights into the current state of clinical research in the oncology community and how technologies and new models are impacting this area.
Sibel Blau, MD, provides insights into the current state of clinical research in the oncology community and how technologies and new models are impacting this area.
Sibel Blau, MD, provides...
11/02/2023
Journal of Clinical Pathways
Dan Nardi, Reimagine Care.
Videos
The Future of Cancer Care At Home
10/25/2023
Dan Nardi
Dan Nardi, CEO of Reimagine Care, details his session on the future of cancer care in the home at the 2023 CPC+CBEx conference.
Dan Nardi, CEO of Reimagine Care, details his session on the future of cancer care in the home at the 2023 CPC+CBEx conference.
Dan Nardi, CEO of Reimagine...
10/25/2023
Journal of Clinical Pathways
Debyani Chakravarty, PhD.
Videos
How Precision Medicine is Changing Cancer Care
10/25/2023
Debyani Chakravarty, PhD
Debyani Chakravarty, PhD, from the Memorial Sloan Kettering Cancer Center, details her session on scaling precision medicine for equitable cancer care at the 2023 CPC+CBEx conference.
Debyani Chakravarty, PhD, from the Memorial Sloan Kettering Cancer Center, details her session on scaling precision medicine for equitable cancer care at the 2023 CPC+CBEx conference.
Debyani Chakravarty, PhD, from...
10/25/2023
Journal of Clinical Pathways
Amy Valley and the AI panel from CPC+CBEx.
News
AI in Cancer Care: Navigating the Current Landscape and Future Possibilities
10/24/2023
Brandon Twyford
During the “AI in Cancer Care: Separating Fact from Fiction" session at CPC & CBEx 2023, Ira Klein, MD, Amy Valley, PharmD, James Hamrick, MD, Ed Rodgers, Will Shapiro, and Zachary Taft, MBA, delved into the present applications and future...
During the “AI in Cancer Care: Separating Fact from Fiction" session at CPC & CBEx 2023, Ira Klein, MD, Amy Valley, PharmD, James Hamrick, MD, Ed Rodgers, Will Shapiro, and Zachary Taft, MBA, delved into the present applications and future...
During the “AI in Cancer Care:...
10/24/2023
Journal of Clinical Pathways
Chevon Rariy, MD
Videos
How Pathways Can Aid in Managing Patient Cost of Care
10/23/2023
Chevon Rariy, MD
Chevon Rariy, MD, Oncology Care Partners, discusses how clinical pathways can help in providing personalized treatment to patients and managing patient cost of care.
Chevon Rariy, MD, Oncology Care Partners, discusses how clinical pathways can help in providing personalized treatment to patients and managing patient cost of care.
Chevon Rariy, MD, Oncology Care...
10/23/2023
Journal of Clinical Pathways
Ivy Altomare, MD
Videos
Reimagining Clinical Trials in the Community Setting
10/20/2023
Ivy Altomare, MD
Ivy Altomare, MD, Flatiron Health, discusses the current state of clinical research in community oncology and how technologies and new models are changing clinical research.
Ivy Altomare, MD, Flatiron Health, discusses the current state of clinical research in community oncology and how technologies and new models are changing clinical research.
Ivy Altomare, MD, Flatiron...
10/20/2023
Journal of Clinical Pathways
News
New Dimensions in Comprehensive Genomic Testing
10/17/2023
Grace Taylor, MS, MA
Eric Severson, MD, PhD, Labcorp Oncology, examines genomic testing’s role in comprehensive oncology pathways.
Eric Severson, MD, PhD, Labcorp Oncology, examines genomic testing’s role in comprehensive oncology pathways.
Eric Severson, MD, PhD, Labcorp...
10/17/2023
Journal of Clinical Pathways
Conference Coverage
Treating the Individual: The Intersection of Personalized Medicine and Clinical Pathways
10/16/2023
Grace Taylor, MS, MA
Ray Page, DO, PhD, discusses how personalized medicine and clinical pathways intersect in ways that help drive the best outcomes for patients, and Mary E. Cooley, PhD, RN, FAAN, and David F. Lobach, MD, PhD, MS, Elimu Informatics, provide an...
Ray Page, DO, PhD, discusses how personalized medicine and clinical pathways intersect in ways that help drive the best outcomes for patients, and Mary E. Cooley, PhD, RN, FAAN, and David F. Lobach, MD, PhD, MS, Elimu Informatics, provide an...
Ray Page, DO, PhD, discusses how...
10/16/2023
Journal of Clinical Pathways
The role of cost in pathways panel discussion at CPC & CBEx 2023.
News
The Evolving Role of Cost in Pathways: Cost of Care, Cost Avoidance, and Patient Costs
10/12/2023
Brandon Twyford
Sunday’s day of sessions at CPC & CBEx 2023 included a panel on “The Evolving Role of Cost in Pathways: Cost of Care, Cost Avoidance, and Patient Costs,” where participants investigated factors beyond drug costs that affect the bottom line...
Sunday’s day of sessions at CPC & CBEx 2023 included a panel on “The Evolving Role of Cost in Pathways: Cost of Care, Cost Avoidance, and Patient Costs,” where participants investigated factors beyond drug costs that affect the bottom line...
Sunday’s day of sessions at CPC...
10/12/2023
Journal of Clinical Pathways
News
Pathway Use Beyond the Unidimensional Treatment Decision
10/11/2023
Grace Taylor, MS, MA
Stephen B. Edge, MD, Roswell Park Comprehensive Cancer Center, provides an overview of how clinical pathways are utilized at Roswell Park.
Stephen B. Edge, MD, Roswell Park Comprehensive Cancer Center, provides an overview of how clinical pathways are utilized at Roswell Park.
Stephen B. Edge, MD, Roswell...
10/11/2023
Journal of Clinical Pathways
News
Cancer Care at Home: Opportunities, Risks, and How to Prepare
10/11/2023
Grace Taylor, MS, MA
Aaron Gerber, Raj Hazarika, Barbara McAneny, Barry Russo, Harlan Levine, and Lindsey Zinck explore the potential of cancer care at home and the challenges it may bring.
Aaron Gerber, Raj Hazarika, Barbara McAneny, Barry Russo, Harlan Levine, and Lindsey Zinck explore the potential of cancer care at home and the challenges it may bring.
Aaron Gerber, Raj Hazarika,...
10/11/2023
Journal of Clinical Pathways
The Scaling Precision Medicine panel at CPC & CBEx 2023.
News
Scaling Precision Medicine Expertise for Equitable Cancer Care: Breaking Barriers, Advancing Patient Outcomes
10/10/2023
Brandon Twyford
Ivy Altomare, MD, Debyani Chakravarty, PhD, James Hamrick, MD, and John W. Sweetenham, MD, discussed the ways precision medicine can help advance equity in health care at CPC & CBEx 2023 in Boston.
Ivy Altomare, MD, Debyani Chakravarty, PhD, James Hamrick, MD, and John W. Sweetenham, MD, discussed the ways precision medicine can help advance equity in health care at CPC & CBEx 2023 in Boston.
Ivy Altomare, MD, Debyani...
10/10/2023
Journal of Clinical Pathways
Frederick Schnell, MD, Nicolas Ferreyros, and Barbara McAneny, MD, discuss health care advocacy and policy at CPC & CBEx 2023
News
How Congress Plans to Address Patient and Hospital Challenges, and How This Could Affect Oncologists
10/10/2023
Emry Lloyd
At CPC & CBEx 2023, Barbara McAneny, MD, Nicolas Ferreyros, and Frederick Schnell, MD, shared insight into Congress’s plan to address specific patient and hospital concerns, and how it might affect oncologists.
At CPC & CBEx 2023, Barbara McAneny, MD, Nicolas Ferreyros, and Frederick Schnell, MD, shared insight into Congress’s plan to address specific patient and hospital concerns, and how it might affect oncologists.
At CPC & CBEx 2023, Barbara...
10/10/2023
Journal of Clinical Pathways
Will Shapiro, Flatiron Health
Conference Coverage
The Future of AI in Cancer Care
10/08/2023
Will Shapiro
Will Shapiro, vice president of Data Insights Engineering at Flatiron Health, shares insights into recent developments in the use of AI in cancer care and what advances are anticipated in this area.
Will Shapiro, vice president of Data Insights Engineering at Flatiron Health, shares insights into recent developments in the use of AI in cancer care and what advances are anticipated in this area.
Will Shapiro, vice president of...
10/08/2023
Journal of Clinical Pathways
Conference Coverage
The Impact of Health Care Industry Consolidation on Cancer Care and Partnerships
10/08/2023
Emry Lloyd
Ronald Barkley, Barbara McAneny, Harlan Levine, and Todd Schonherz discuss the challenges and benefits of health care industry consolidation.
Ronald Barkley, Barbara McAneny, Harlan Levine, and Todd Schonherz discuss the challenges and benefits of health care industry consolidation.
Ronald Barkley, Barbara McAneny,...
10/08/2023
Journal of Clinical Pathways
News
CPC & CBEx Keynote Session: How Do We Define Value-Based Oncology Care?
10/07/2023
Brandon Twyford
The keynote session from the 2023 CPC & CBEx Annual Conference featured Harlan Levine, MD, City of Hope, in a thought-provoking presentation on what "value" in value-based care really means, and how to achieve a truly patient-centered model...
The keynote session from the 2023 CPC & CBEx Annual Conference featured Harlan Levine, MD, City of Hope, in a thought-provoking presentation on what "value" in value-based care really means, and how to achieve a truly patient-centered model...
The keynote session from the...
10/07/2023
Journal of Clinical Pathways
Conference Coverage
Using Clinical Pathways to Reduce Delays in Time to Treatment
10/07/2023
Grace Taylor, MS, MA
At CPC & CBEx 2023, Dennis R. Holmes, MD, discusses the impacts of delays in time to treatment for patients and how physician can use clinical pathways to provide more efficient treatment.
At CPC & CBEx 2023, Dennis R. Holmes, MD, discusses the impacts of delays in time to treatment for patients and how physician can use clinical pathways to provide more efficient treatment.
At CPC & CBEx 2023, Dennis R....
10/07/2023
Journal of Clinical Pathways
News
How Clinical Pathways Can be Used For HER2-Positive Breast Cancer Therapies
10/07/2023
Emry Lloyd
At CPC & CBEx 2023, Sayeh Lavasani, MD, discussed the different ways clinical pathways can be followed for HER2-positive breast cancer therapies.
At CPC & CBEx 2023, Sayeh Lavasani, MD, discussed the different ways clinical pathways can be followed for HER2-positive breast cancer therapies.
At CPC & CBEx 2023, Sayeh...
10/07/2023
Journal of Clinical Pathways
News
CPC & CBEx 2023: Critical Trends in the Oncology Landscape
10/06/2023
Brandon Twyford
To open Friday’s schedule of sessions at the Clinical Pathways Congress & Cancer Care Business Exchange, Lee Blansett, MBA, Executive Vice President for HMP Market Access Insights, discussed critical trends in today’s oncology...
To open Friday’s schedule of sessions at the Clinical Pathways Congress & Cancer Care Business Exchange, Lee Blansett, MBA, Executive Vice President for HMP Market Access Insights, discussed critical trends in today’s oncology...
To open Friday’s schedule of...
10/06/2023
Cancer Care Business Exchange
James Hamrick, MD
Conference Coverage
AI in Cancer Care: Separating Fact from Fiction
10/06/2023
James Hamrick, MD, MPH
James Hamrick, MD, discusses his presentation "AI in Cancer Care: Separating Fact from Fiction" at the 2023 Clinical Pathways Congress + Cancer Care Business Exchange meeting.
James Hamrick, MD, discusses his presentation "AI in Cancer Care: Separating Fact from Fiction" at the 2023 Clinical Pathways Congress + Cancer Care Business Exchange meeting.
James Hamrick, MD, discusses his...
10/06/2023
Journal of Clinical Pathways
Barbara McAneny, MD
Conference Coverage
CPC & CBEx Session Preview: Updates from Washington, Healthcare Industry Consolidation, and Cancer Care at Home
10/03/2023
Barbara McAneny, MD
CPC & CBEx faculty member Barbara McAneny, MD, gives a preview of her three featured sessions from the conference, including key points on health care industry consolidation, legislative updates, and important considerations for delivering...
CPC & CBEx faculty member Barbara McAneny, MD, gives a preview of her three featured sessions from the conference, including key points on health care industry consolidation, legislative updates, and important considerations for delivering...
CPC & CBEx faculty member...
10/03/2023
Journal of Clinical Pathways
The Hunt for Value in Value-Based Care
Videos
The Hunt for Value in Value-Based Care: How to Meet Stakeholders' Evolving Demands
09/18/2023
Frederick M. Schnell, MD, FACP
Frederick Schnell, MD, FACP, Community Oncology Alliance, previews his session at CPC + CBEx in October on market dynamics that are affecting the implementation of value-based cancer care.
Frederick Schnell, MD, FACP, Community Oncology Alliance, previews his session at CPC + CBEx in October on market dynamics that are affecting the implementation of value-based cancer care.
Frederick Schnell, MD, FACP,...
09/18/2023
Journal of Clinical Pathways
James Hamrick Teaser Thumbnail
Videos
Scaling Precision Medicine Expertise for Equitable Cancer Care: Breaking Barriers, Advancing Patient Outcomes
09/08/2023
James Hamrick, MD, MPH
In this video, James Hamrick, MD, MPH, Flatiron Health, previews his session at CPC + CBEx in October on the importance of precision medicine in delivering equitable cancer care.
In this video, James Hamrick, MD, MPH, Flatiron Health, previews his session at CPC + CBEx in October on the importance of precision medicine in delivering equitable cancer care.
In this video, James Hamrick,...
09/08/2023
Cancer Care Business Exchange
Cancer Care At Home
Videos
Cancer Care at Home: Opportunities, Risks, and How to Prepare
08/18/2023
John Hennessy, MBA
CBEx Advisory Board Member John Hennessy, MBA, Valuate Health Consultancy, previews his featured CPC+CBEx meeting session, “Cancer Care at Home: Opportunities, Risks, and How to Prepare.”
CBEx Advisory Board Member John Hennessy, MBA, Valuate Health Consultancy, previews his featured CPC+CBEx meeting session, “Cancer Care at Home: Opportunities, Risks, and How to Prepare.”
CBEx Advisory Board Member John...
08/18/2023
Cancer Care Business Exchange
Video preview thumbnail.
Videos
“Treating the Person: Integrating Support Services into Clinical Pathways” at the Clinical Pathways Congress with the Cancer Care Business Exchange
08/11/2023
Mary Cooley, PhD, Dana-Farber Cancer Institute, and David Lobach, MD, Elimu Informatics, provide an inside look into their CPC session “Treating the Person: Integrating Support Services into Clinical Pathways.”
Mary Cooley, PhD, Dana-Farber Cancer Institute, and David Lobach, MD, Elimu Informatics, provide an inside look into their CPC session “Treating the Person: Integrating Support Services into Clinical Pathways.”
Mary Cooley, PhD, Dana-Farber...
08/11/2023
Journal of Clinical Pathways
Video thumbnail.
Videos
AI in Cancer Care: Separating Fact from Fiction
07/17/2023
Ira Klein, MD, MBA, FACP
CBEx Advisory Board Member Ira Klein, MD, VP of Medical Affairs for Tempus Labs, provides an inside look into featured session "AI in Cancer Care: Separating Fact from Fiction."
CBEx Advisory Board Member Ira Klein, MD, VP of Medical Affairs for Tempus Labs, provides an inside look into featured session "AI in Cancer Care: Separating Fact from Fiction."
CBEx Advisory Board Member Ira...
07/17/2023
Cancer Care Business Exchange
Tatjana Kolevska, MD
Videos
Clinical Pathways: The Future of Cancer Care
11/21/2022
Tatjana Kolevska, MD, medical oncologist at Kaiser Permanente and medical director of the Kaiser Permanente National Cancer Excellence Program, discusses her presentation on the growing need for clinical pathways and the future of cancer care.
Tatjana Kolevska, MD, medical oncologist at Kaiser Permanente and medical director of the Kaiser Permanente National Cancer Excellence Program, discusses her presentation on the growing need for clinical pathways and the future of cancer care.
Tatjana Kolevska, MD, medical...
11/21/2022
Journal of Clinical Pathways
Michael Kolodziej, MD
Videos
ePROs Play a Key Role in Personalized Therapy
11/17/2022
Michael Kolodziej, MD, Advisor, Canopy, discusses at the 2022 Oncology Clinical Pathways Congress how electronic patient-reported outcomes and electronic engagement with patients can aid improve outcomes.
Michael Kolodziej, MD, Advisor, Canopy, discusses at the 2022 Oncology Clinical Pathways Congress how electronic patient-reported outcomes and electronic engagement with patients can aid improve outcomes.
Michael Kolodziej, MD, Advisor,...
11/17/2022
Journal of Clinical Pathways
Lee Fleisher, MD
Videos
Making Clinical Pathways Unique to the Patient Journey
11/14/2022
Lee Fleisher, MD, discusses balancing the need for uniform quality care for all patients with finding the proper pathways for individual patients.
Lee Fleisher, MD, discusses balancing the need for uniform quality care for all patients with finding the proper pathways for individual patients.
Lee Fleisher, MD, discusses...
11/14/2022
Journal of Clinical Pathways
Nisha Joseph, MD
Videos
The Use of Clinical Pathways in the Treatment of Patients With Multiple Myeloma
11/14/2022
Nisha Joseph, MD, discusses antibodies in myeloma and the use of clinical pathways in the treatment of patients with multiple myeloma, touching on new, “ever-evolving” therapeutics and recent drug approvals in the multiple myeloma space.
Nisha Joseph, MD, discusses antibodies in myeloma and the use of clinical pathways in the treatment of patients with multiple myeloma, touching on new, “ever-evolving” therapeutics and recent drug approvals in the multiple myeloma space.
Nisha Joseph, MD, discusses...
11/14/2022
Journal of Clinical Pathways
Lee Fleisher, MD
Interview
CMS National Quality Strategy Focuses on Quality, Safety, Affordability Standards in Oncology Care
11/10/2022
Lee Fleisher, MD, outlines the foundation and goals of the Centers for Medicare and Medicaid Services’ National Quality Strategy, highlighting key components such as quality, safety, and affordability, and emphasizing alignment between all of...
Lee Fleisher, MD, outlines the foundation and goals of the Centers for Medicare and Medicaid Services’ National Quality Strategy, highlighting key components such as quality, safety, and affordability, and emphasizing alignment between all of...
Lee Fleisher, MD, outlines the...
11/10/2022
Journal of Clinical Pathways
Janet Espirito, PharmD
Videos
Integrating Biomarker Testing Into Clinical Pathways to Optimize the NSCLC Treatment Landscape
11/03/2022
Janet Espirito, PharmD, discusses the importance of education, awareness of technology, and support for providers and patients to utilize comprehensive testing so that patients can receive the proper treatment at the right time.
Janet Espirito, PharmD, discusses the importance of education, awareness of technology, and support for providers and patients to utilize comprehensive testing so that patients can receive the proper treatment at the right time.
Janet Espirito, PharmD,...
11/03/2022
Journal of Clinical Pathways
Elliot Fishman, MD
Videos
Establishing Imaging Guidelines Within Oncology Pathways
11/02/2022
Elliot Fishman, MD, discusses imagining guidelines and the optimization of health care within oncology.
Elliot Fishman, MD, discusses imagining guidelines and the optimization of health care within oncology.
Elliot Fishman, MD, discusses...
11/02/2022
Journal of Clinical Pathways
Matthew Lunning, DO, FACP
Videos
Telehealth Utilization in Clinical Trial Research and Participation
10/27/2022
Matthew Lunning, DO, FACP, discusses the expansion of telehealth during the “COVID era,” highlighting the importance of face-to-face encounters between patients and health care providers, and suggesting ways to successfully meet this demand...
Matthew Lunning, DO, FACP, discusses the expansion of telehealth during the “COVID era,” highlighting the importance of face-to-face encounters between patients and health care providers, and suggesting ways to successfully meet this demand...
Matthew Lunning, DO, FACP,...
10/27/2022
Journal of Clinical Pathways
Ira Klein, MD
Videos
Optimizing Clinical Trials in Academia and Community Oncology
10/27/2022
Ira Klein, MD, discusses design in clinical trials, touching on current issues such as clinical workflow and operational processes, and the barriers to participating in a clinical trial in community oncology.
Ira Klein, MD, discusses design in clinical trials, touching on current issues such as clinical workflow and operational processes, and the barriers to participating in a clinical trial in community oncology.
Ira Klein, MD, discusses design...
10/27/2022
Journal of Clinical Pathways
Conference Coverage
Optimal Utilization of Telehealth to Enhance Patient Care and Clinical Trial Participation
10/18/2022
Katie Herman; Craig Ostroff
Matthew A Lunning, DO, FACP, Associate Professor, Fred & Pamela Buffett Cancer Center, Associate Vice-Chair of Research Department of Medicine, Assistant Vice Chancellor of Clinical Research, University of Nebraska Medical Center, Omaha,...
Matthew A Lunning, DO, FACP, Associate Professor, Fred & Pamela Buffett Cancer Center, Associate Vice-Chair of Research Department of Medicine, Assistant Vice Chancellor of Clinical Research, University of Nebraska Medical Center, Omaha,...
Matthew A Lunning, DO, FACP,...
10/18/2022
Journal of Clinical Pathways
Conference Coverage
Just in Time Clinical Trials: A Solution for Both Academia and Community Oncology
10/18/2022
Craig Ostroff
At the 2022 Oncology Clinical Pathways Congress, Dr Ira Klein discussed the need to improve access and reach typically underrepresented populations in order to make clinical trials and cancer treatment studies more representative of the...
At the 2022 Oncology Clinical Pathways Congress, Dr Ira Klein discussed the need to improve access and reach typically underrepresented populations in order to make clinical trials and cancer treatment studies more representative of the...
At the 2022 Oncology Clinical...
10/18/2022
Journal of Clinical Pathways
Conference Coverage
CancerLinQ Technology in the Oncology Community
10/17/2022
Katie Herman; Craig Ostroff
Robert S. Miller, MD, FACP, FASCO, FAMIA, Chief Medical Science Officer, CancerLinQ, American Society of Clinical Oncology, described how data aggregation and analytic platforms are aiding in clinical decision support and explained current...
Robert S. Miller, MD, FACP, FASCO, FAMIA, Chief Medical Science Officer, CancerLinQ, American Society of Clinical Oncology, described how data aggregation and analytic platforms are aiding in clinical decision support and explained current...
Robert S. Miller, MD, FACP,...
10/17/2022
Journal of Clinical Pathways
Conference Coverage
ePROs Effect on Patient Health Outcomes
10/17/2022
Katie Herman; Craig Ostroff
Michael Kolodziej, MD, Senior Advisor, ADVI, presented that patient monitoring during treatment using electronic patient-reported outcomes significantly improves results.
Michael Kolodziej, MD, Senior Advisor, ADVI, presented that patient monitoring during treatment using electronic patient-reported outcomes significantly improves results.
Michael Kolodziej, MD, Senior...
10/17/2022
Journal of Clinical Pathways
Conference Coverage
Precision Medicine and AI in Oncology Patient Care
10/16/2022
Katie Herman; Craig Ostroff
Tushar Pandey, CEO, SimBioSys, Inc, in his 2022 Oncology Clinical Pathways Congress presented on the value artificial intelligence brings to oncology patient care, and the need to move to guided intelligence.
Tushar Pandey, CEO, SimBioSys, Inc, in his 2022 Oncology Clinical Pathways Congress presented on the value artificial intelligence brings to oncology patient care, and the need to move to guided intelligence.
Tushar Pandey, CEO, SimBioSys,...
10/16/2022
Journal of Clinical Pathways
Daniel Vaena, MD
Videos
The Challenges and Evolution of Pathways in Urothelial Carcinoma
10/16/2022
Daniel Vaena, MD, West Cancer Center and Research Institute, summarizes his 2022 Oncology Clinical Pathways Congress presentation that covers the evolution and unmet needs of the pathways in metastatic urothelial cancer and the disparities in...
Daniel Vaena, MD, West Cancer Center and Research Institute, summarizes his 2022 Oncology Clinical Pathways Congress presentation that covers the evolution and unmet needs of the pathways in metastatic urothelial cancer and the disparities in...
Daniel Vaena, MD, West Cancer...
10/16/2022
Journal of Clinical Pathways
Sibel Blau, MD
Videos
Creating and Implementing Value-Based Pathways in Community Oncology
10/16/2022
Sibel Blau, MD, Northwest Medical Specialties, summarizes her 2022 Oncology Clinical Pathways Congress presentation on creating and implementing value-based care pathways and the associated challenges in the health care system.
Sibel Blau, MD, Northwest Medical Specialties, summarizes her 2022 Oncology Clinical Pathways Congress presentation on creating and implementing value-based care pathways and the associated challenges in the health care system.
Sibel Blau, MD, Northwest...
10/16/2022
Journal of Clinical Pathways
Conference Coverage
Low-Value Care Directly Leads to Development of Cancer Genomic Pathways
10/16/2022
Katie Herman; Craig Ostroff
Tatjana Kolevska, MD, explains at the 2022 Oncology Clinical Pathways Conference that digital pathways are the way of the future in regard to cancer care.
Tatjana Kolevska, MD, explains at the 2022 Oncology Clinical Pathways Conference that digital pathways are the way of the future in regard to cancer care.
Tatjana Kolevska, MD, explains...
10/16/2022
Journal of Clinical Pathways
Conference Coverage
Gene Sequencing in the Clinic
10/16/2022
Katie Herman; Craig Ostroff
Mahek Shah, MD, MBA, MS, at the 2022 Oncology Clinical Pathways Congress, discussed the need to enable gene sequencing-as-a-service in clinical settings and what that means for future clinical care.
Mahek Shah, MD, MBA, MS, at the 2022 Oncology Clinical Pathways Congress, discussed the need to enable gene sequencing-as-a-service in clinical settings and what that means for future clinical care.
Mahek Shah, MD, MBA, MS, at the...
10/16/2022
Journal of Clinical Pathways
Lawrence Shulman, MD
Videos
Complexities in Current Cancer Care Systems and Strategies for Providing High-Level Patient Care
10/16/2022
At the 2022 Oncology Clinical Pathways Congress, Lawrence Shulman, MD, discusses the need for having critical systems in place and unencumbered access to patient data to achieve optimal care, and emphasizes the role that coordinated clinical...
At the 2022 Oncology Clinical Pathways Congress, Lawrence Shulman, MD, discusses the need for having critical systems in place and unencumbered access to patient data to achieve optimal care, and emphasizes the role that coordinated clinical...
At the 2022 Oncology Clinical...
10/16/2022
Journal of Clinical Pathways
Conference Coverage
Complex Diagnostic Imaging and the CMS Imaging AUC Program
10/16/2022
Katie Herman; Craig Ostroff
Elliot K Fishman, MD, FACR, Professor of Radiology, Oncology, Surgery and Urology, Johns Hopkins Hospital, presented at the 2022 Oncology Clinical Pathways Congress about Medicare’s Appropriate Use Criteria program and the challenges in...
Elliot K Fishman, MD, FACR, Professor of Radiology, Oncology, Surgery and Urology, Johns Hopkins Hospital, presented at the 2022 Oncology Clinical Pathways Congress about Medicare’s Appropriate Use Criteria program and the challenges in...
Elliot K Fishman, MD, FACR,...
10/16/2022
Journal of Clinical Pathways
Conference Coverage
Integrating Social Determinants of Health
10/16/2022
Katie Herman; Craig Ostroff
At the 2022 Oncology Clinical Pathways Congress, Mishellene McKinney, MHA, RN, OCN, Vice President, Cancer Care Services, Kaiser Permanente; and Anand Shah, MD, MS, Vice President, Social Health, Kaiser Permanente, discussed the importance of...
At the 2022 Oncology Clinical Pathways Congress, Mishellene McKinney, MHA, RN, OCN, Vice President, Cancer Care Services, Kaiser Permanente; and Anand Shah, MD, MS, Vice President, Social Health, Kaiser Permanente, discussed the importance of...
At the 2022 Oncology Clinical...
10/16/2022
Journal of Clinical Pathways
Sayeh Lavasani, MD, MS, FRCPC
Videos
Utilizing Pathways to Mitigate Costs in Metastatic Breast Cancer Treatment
10/16/2022
Sayeh Lavasani, MD, MS, FRCPC, highlights the financial advantage of pathways, stating that clinical pathway utilization can save up to 35% in the cost of treatment in breast cancer, while providing up-to-date, evidence-based treatment...
Sayeh Lavasani, MD, MS, FRCPC, highlights the financial advantage of pathways, stating that clinical pathway utilization can save up to 35% in the cost of treatment in breast cancer, while providing up-to-date, evidence-based treatment...
Sayeh Lavasani, MD, MS, FRCPC,...
10/16/2022
Journal of Clinical Pathways
Conference Coverage
Cancer Care Equity and Collaboration
10/16/2022
Katie Herman; Craig Ostroff
At the 2022 Oncology Clinical Pathways Congress, Lawrence N Shulman, MD, Abramson Cancer Center University of Pennsylvania, summarized the status of cancer care in the United States and proposed how collaborative care can enhance quality of...
At the 2022 Oncology Clinical Pathways Congress, Lawrence N Shulman, MD, Abramson Cancer Center University of Pennsylvania, summarized the status of cancer care in the United States and proposed how collaborative care can enhance quality of...
At the 2022 Oncology Clinical...
10/16/2022
Journal of Clinical Pathways
Conference Coverage
Value-Based Oncology Care Solutions for Self-Insured Employers
10/15/2022
Craig Ostroff
At the 2022 Oncology Clinical Pathways Congress, Margaret Rehayem, Vice President of the National Alliance of Healthcare Purchaser Coalitions, spoke on the dramatic effect that developments in cancer care have had on employers and employees.
At the 2022 Oncology Clinical Pathways Congress, Margaret Rehayem, Vice President of the National Alliance of Healthcare Purchaser Coalitions, spoke on the dramatic effect that developments in cancer care have had on employers and employees.
At the 2022 Oncology Clinical...
10/15/2022
Journal of Clinical Pathways
Conference Coverage
Optimizing Oncology Care in Older Adults
10/15/2022
Craig Ostroff; Katie Herman
Kjel A. Johnson, PharmD, Vice President, Specialty Product Strategy CVS Health, presented at the 2022 Oncology Clinical Pathways Congress regarding optimizing patient care in older adults from an operational and integrational perspective.
Kjel A. Johnson, PharmD, Vice President, Specialty Product Strategy CVS Health, presented at the 2022 Oncology Clinical Pathways Congress regarding optimizing patient care in older adults from an operational and integrational perspective.
Kjel A. Johnson, PharmD, Vice...
10/15/2022
Journal of Clinical Pathways
Conference Coverage
Quality of Care and Research Initiatives in the Enhancing Oncology Model
10/15/2022
Katie Herman; Craig Ostroff
Lee A. Fleisher, MD, CMS Chief Medical Officer, Director, Center for Clinical Standards and Quality, presented data at the 2022 Oncology Clinical Pathways Congress regarding the Oncology Care Model as well as the development plan for the...
Lee A. Fleisher, MD, CMS Chief Medical Officer, Director, Center for Clinical Standards and Quality, presented data at the 2022 Oncology Clinical Pathways Congress regarding the Oncology Care Model as well as the development plan for the...
Lee A. Fleisher, MD, CMS Chief...
10/15/2022
Journal of Clinical Pathways
Conference Coverage
The State of Clinical Pathways – 2022 Survey Results
10/15/2022
Katie Herman
The Journal of Clinical Pathways’ Editor-in-Chief, Winston Wong, PharmD, presented results from the publication’s 5th annual benchmarking survey at the 2022 Oncology Clinical Pathways Congress, stating a trend in increased demand for improved...
The Journal of Clinical Pathways’ Editor-in-Chief, Winston Wong, PharmD, presented results from the publication’s 5th annual benchmarking survey at the 2022 Oncology Clinical Pathways Congress, stating a trend in increased demand for improved...
The Journal of Clinical...
10/15/2022
Journal of Clinical Pathways
Conference Coverage
Pharmacy Benefits With Rising Costs of Cancer Care
10/15/2022
Craig Ostroff
Sibel Blau, MD, Medical Director at Northwest Medical Specialties, PLLC, and James Gelfand, President of the ERISA Industry Committee, presented at the 2022 Oncology Clinical Pathways Congress about pharmacy benefits in value-based pathways.
Sibel Blau, MD, Medical Director at Northwest Medical Specialties, PLLC, and James Gelfand, President of the ERISA Industry Committee, presented at the 2022 Oncology Clinical Pathways Congress about pharmacy benefits in value-based pathways.
Sibel Blau, MD, Medical Director...
10/15/2022
Journal of Clinical Pathways
Margaret Rehayem
Videos
Value-Based Oncology Care Solutions for Self-Insured Employers
10/15/2022
At the 2022 Oncology Clinical Pathways Congress, Margaret Rehayem, MA, National Alliance of Healthcare Purchaser Coalitions, takes the employer perspective on value-based care with technology advancements and how to help an employer look at...
At the 2022 Oncology Clinical Pathways Congress, Margaret Rehayem, MA, National Alliance of Healthcare Purchaser Coalitions, takes the employer perspective on value-based care with technology advancements and how to help an employer look at...
At the 2022 Oncology Clinical...
10/15/2022
Journal of Clinical Pathways
Tatjana Kolevska, MD
Videos
Utilizing Pathways for Diagnosis, Treatment, and Survivorship in Cancer Care
10/15/2022
Tatjana Kolevska, MD, Kaiser Permanente, presents at the 2022 Oncology Clinical Pathways Congress the importance of connecting all specialties in pathways, meaning screening, diagnosis, treatment, and survivorship, for consistent and up to...
Tatjana Kolevska, MD, Kaiser Permanente, presents at the 2022 Oncology Clinical Pathways Congress the importance of connecting all specialties in pathways, meaning screening, diagnosis, treatment, and survivorship, for consistent and up to...
Tatjana Kolevska, MD, Kaiser...
10/15/2022
Journal of Clinical Pathways
Louis Culot
Videos
The Role of Technology in Improving Oncology Pathways
10/15/2022
Louis Culot, Philips Healthcare, discusses at the 2022 Oncology Clinical Pathways Congress how technology plays a central role in developing and improving clinical oncology pathways and also the barriers technology faces today.
Louis Culot, Philips Healthcare, discusses at the 2022 Oncology Clinical Pathways Congress how technology plays a central role in developing and improving clinical oncology pathways and also the barriers technology faces today.
Louis Culot, Philips Healthcare,...
10/15/2022
Journal of Clinical Pathways
Conference Coverage
System Challenges in Oncology Care—A Patient Perspective
10/15/2022
Craig Ostroff
Kellee Franklin, PhD, Chief Innovation Officer at Mindful Innovation Labs, strategic innovation consultant, shared her journey of her cancer diagnosis in 2013 and the challenges she faced with the system.
Kellee Franklin, PhD, Chief Innovation Officer at Mindful Innovation Labs, strategic innovation consultant, shared her journey of her cancer diagnosis in 2013 and the challenges she faced with the system.
Kellee Franklin, PhD, Chief...
10/15/2022
Journal of Clinical Pathways
Conference Coverage
Health Equity and Care Coordination From the Patient Perspective
10/15/2022
Craig Ostroff
Deborah Collyar, President of Patient Advocates In Research, and a cancer survivor, presented at the 2022 Oncology Clinical Pathways Congress on patient perspective in cancer care for pathways and care coordination, emphasizing health equity.
Deborah Collyar, President of Patient Advocates In Research, and a cancer survivor, presented at the 2022 Oncology Clinical Pathways Congress on patient perspective in cancer care for pathways and care coordination, emphasizing health equity.
Deborah Collyar, President of...
10/15/2022
Journal of Clinical Pathways
Conference Coverage
Value-Based Care and COVID-19
10/15/2022
Craig Ostroff
At the 2022 Oncology Clinical Pathways Congress, Mahek A. Shah, MD, MBA, MS, Physician Executive, Investor, Advisor and Managing Partner Harvard University and WTM Advisors; Harvard School of Public Health and Brigham Health, Ariadne Labs,...
At the 2022 Oncology Clinical Pathways Congress, Mahek A. Shah, MD, MBA, MS, Physician Executive, Investor, Advisor and Managing Partner Harvard University and WTM Advisors; Harvard School of Public Health and Brigham Health, Ariadne Labs,...
At the 2022 Oncology Clinical...
10/15/2022
Journal of Clinical Pathways
Conference Coverage
Using Real-Time Dynamics to Enhance Clinical Pathways
10/15/2022
Craig Ostroff
Davey Daniel, MD, Chief Medical Officer, OneOncology, discussed at the 2022 Oncology Clinical Pathways Congress the need is to identify forces that are shaping pathways, and to learn how to build systems to support and enhance those pathways.
Davey Daniel, MD, Chief Medical Officer, OneOncology, discussed at the 2022 Oncology Clinical Pathways Congress the need is to identify forces that are shaping pathways, and to learn how to build systems to support and enhance those pathways.
Davey Daniel, MD, Chief Medical...
10/15/2022
Journal of Clinical Pathways
Conference Coverage
Decision Support Through Structured Data
10/14/2022
Craig Ostroff
At the 2022 Oncology Clinical Pathways Congress, Mary M. Ichiuji, MD, Kaiser Permanente and National Physician Lead, Beacon Oncology, presented the development of Kaiser Permanente Beacon Oncology Module EPIC, a patient-centered,...
At the 2022 Oncology Clinical Pathways Congress, Mary M. Ichiuji, MD, Kaiser Permanente and National Physician Lead, Beacon Oncology, presented the development of Kaiser Permanente Beacon Oncology Module EPIC, a patient-centered,...
At the 2022 Oncology Clinical...
10/14/2022
Journal of Clinical Pathways
Conference Coverage
Can Real-World Evidence Improve Clinical Pathways?
10/14/2022
Craig Ostroff
At the 2022 Oncology Clinical Pathway Congress, Rebecca Miksad, MD, MPH, Flatiron Health; and Carole Tremonti, RN, MBA, Three Mountains LLC, presented how population-level data provides specificity and creates value in aiding decision-making.
At the 2022 Oncology Clinical Pathway Congress, Rebecca Miksad, MD, MPH, Flatiron Health; and Carole Tremonti, RN, MBA, Three Mountains LLC, presented how population-level data provides specificity and creates value in aiding decision-making.
At the 2022 Oncology Clinical...
10/14/2022
Journal of Clinical Pathways
James Gelfand, JD
Videos
Analyzing Pharmacy Benefits in Value-Based Oncology Pathways
10/14/2022
James Gelfand, JD, The ERISA Industry Committee, discusses achieving optimal, value-driven patient care through pharmacy benefit managers, and changes in plan transparency for payers and patients at the 2022 Oncology Clinical Pathways...
James Gelfand, JD, The ERISA Industry Committee, discusses achieving optimal, value-driven patient care through pharmacy benefit managers, and changes in plan transparency for payers and patients at the 2022 Oncology Clinical Pathways...
James Gelfand, JD, The ERISA...
10/14/2022
Journal of Clinical Pathways
Conference Coverage
Adopting and Scaling Pathways From the Provider and Payer Perspective
10/03/2021
Janelle Bradley
Mahek Shah, MD, and Jennifer Malin, MD, PhD, presented their unique viewpoints on the adoption and scale of oncology clinical pathways from the provider and payer perspective.
Mahek Shah, MD, and Jennifer Malin, MD, PhD, presented their unique viewpoints on the adoption and scale of oncology clinical pathways from the provider and payer perspective.
Mahek Shah, MD, and Jennifer...
10/03/2021
Clinical Pathways
Conference Coverage
Designing Patient-Centered Pathways at Kaiser Permanente
10/02/2021
Marta Rybczynski
Mishellene McKinney, MHA, RN, OCN, discusses how Kaiser Permanente is using Human Centered Design to inform cancer care delivery and survivorship pathway design.
Mishellene McKinney, MHA, RN, OCN, discusses how Kaiser Permanente is using Human Centered Design to inform cancer care delivery and survivorship pathway design.
Mishellene McKinney, MHA, RN,...
10/02/2021
Clinical Pathways
Conference Coverage
Integrating Genetic Testing and Counseling In Routine Cancer Care
10/02/2021
Janelle Bradley
Beth Karlan, MD, explored ways in which clinical pathways can incorporate genetic testing and counseling into routine cancer care.
Beth Karlan, MD, explored ways in which clinical pathways can incorporate genetic testing and counseling into routine cancer care.
Beth Karlan, MD, explored ways...
10/02/2021
Clinical Pathways
Conference Coverage
Improving Survival and Managing Costs in NSCLC Using Clinical Care Pathways
10/01/2021
Marta Rybczynski
Mark Socinski, MD, discussed the current and ever-evolving treatment landscape of NSCLC and the development and implementation of optimal clinical pathways in this complex disease.
Mark Socinski, MD, discussed the current and ever-evolving treatment landscape of NSCLC and the development and implementation of optimal clinical pathways in this complex disease.
Mark Socinski, MD, discussed the...
10/01/2021
Clinical Pathways
Conference Coverage
Oncology Clinical Pathways Benchmarking Survey 2021 Results
09/29/2021
Janelle Bradley
Winston Wong, PharmD, editor-in-chief of the Journal of Clinical Pathways, presented findings from the 2021 Oncology Clinical Pathways Benchmarking Survey.
Winston Wong, PharmD, editor-in-chief of the Journal of Clinical Pathways, presented findings from the 2021 Oncology Clinical Pathways Benchmarking Survey.
Winston Wong, PharmD,...
09/29/2021
Clinical Pathways
Conference Coverage
What to Expect at the 6th Annual Oncology Clinical Pathways Congress
09/29/2021
Janelle Bradley
The 6th Annual Oncology Clinical Pathways Congress kicks off this weekend in a fully virtual format. Join us for three days of engaging sessions starting October 1, 2021.
The 6th Annual Oncology Clinical Pathways Congress kicks off this weekend in a fully virtual format. Join us for three days of engaging sessions starting October 1, 2021.
The 6th Annual Oncology Clinical...
09/29/2021
Clinical Pathways
Videos
Highlights From the 5th Annual Oncology Clinical Pathways Congress
12/10/2020
Winston Wong, PharmD; Robin Zon, MD, FACP, FASCO; and Gordon Kuntz, discuss highlights from the 5th Annual Oncology Clinical Pathways Congress.
Winston Wong, PharmD; Robin Zon, MD, FACP, FASCO; and Gordon Kuntz, discuss highlights from the 5th Annual Oncology Clinical Pathways Congress.
Winston Wong, PharmD; Robin Zon,...
12/10/2020
Clinical Pathways
Videos
Community- and Culturally-Centered Care Pathways
11/24/2020
A panel featuring 2 patient advocacy groups provides a glimpse into how clinical pathways can be reimagined using patient supports, care preferences, cultural experiences, and community environments as starting points for pathway design.
A panel featuring 2 patient advocacy groups provides a glimpse into how clinical pathways can be reimagined using patient supports, care preferences, cultural experiences, and community environments as starting points for pathway design.
A panel featuring 2 patient...
11/24/2020
Clinical Pathways
Videos
Preliminary Findings From the Care Pathways Working Group
11/02/2020
Robin T Zon, MD, FACP, FASCO, Gordon Kuntz, and Winston Wong, PharmD, present preliminary findings of the Care Pathways Working Group, which seeks to identify challenges and actionable solutions for stakeholders as they face the evolving...
Robin T Zon, MD, FACP, FASCO, Gordon Kuntz, and Winston Wong, PharmD, present preliminary findings of the Care Pathways Working Group, which seeks to identify challenges and actionable solutions for stakeholders as they face the evolving...
Robin T Zon, MD, FACP, FASCO,...
11/02/2020
Clinical Pathways
Conference Coverage
Community- and Culturally-Centered Care Pathways
10/18/2020
A panel featuring two patient advocacy groups discussed clinical pathways and how they can be reimagined using patient supports, care preferences, cultural experiences, and community environments as starting points for pathway design.
A panel featuring two patient advocacy groups discussed clinical pathways and how they can be reimagined using patient supports, care preferences, cultural experiences, and community environments as starting points for pathway design.
A panel featuring two patient...
10/18/2020
Clinical Pathways
Conference Coverage
Preliminary Findings From the Care Pathways Working Group
10/18/2020
Robin T Zon, MD, FACP, FASCO, Gordon Kuntz, and Winston Wong, PharmD, gave a joint presentation on the preliminary findings of the Care Pathways Working Group.
Robin T Zon, MD, FACP, FASCO, Gordon Kuntz, and Winston Wong, PharmD, gave a joint presentation on the preliminary findings of the Care Pathways Working Group.
Robin T Zon, MD, FACP, FASCO,...
10/18/2020
Clinical Pathways
Conference Coverage
Provider Perspective on Value: Using Big Data and Pathways to Succeed
10/18/2020
Adding to the discussions on value-based care and insurance design at the Oncology Clinical Pathways Congress, Sibel Blau, MD, and Ray Page, DO, PhD, FACOI, FASCO, presented from the provider perspective.
Adding to the discussions on value-based care and insurance design at the Oncology Clinical Pathways Congress, Sibel Blau, MD, and Ray Page, DO, PhD, FACOI, FASCO, presented from the provider perspective.
Adding to the discussions...
10/18/2020
Clinical Pathways
Conference Coverage
Practical Strategies to Achieve High-Value Care
10/17/2020
Day 2 of the Oncology Clinical Pathways Congress (October16-18) was filled with presentations from pathways experts well-versed in value-based payment models.
Day 2 of the Oncology Clinical Pathways Congress (October16-18) was filled with presentations from pathways experts well-versed in value-based payment models.
Day 2 of the Oncology Clinical...
10/17/2020
Clinical Pathways
Conference Coverage
Aligning Quality, Outcomes Between Providers and Accountable Groups
10/17/2020
A session at the 5th annual Oncology Clinical Pathways Congress addressed how providers and accountable groups can align their quality and outcomes goals, as well as how the health care landscape is influencing changes in this arena.
A session at the 5th annual Oncology Clinical Pathways Congress addressed how providers and accountable groups can align their quality and outcomes goals, as well as how the health care landscape is influencing changes in this arena.
A session at the 5th annual...
10/17/2020
Clinical Pathways
Value-Based Insurance Design in Cancer Care: Right Drug, Right Person, Right Time
Videos
Value-Based Insurance Design in Cancer Care: Right Drug, Right Person, Right Time
10/16/2020
In this video, Sonali Fonseca, PhD, demonstrates how pathways are an important tool to participate in value-based models in a predictable and sustainable manner. 
In this video, Sonali Fonseca, PhD, demonstrates how pathways are an important tool to participate in value-based models in a predictable and sustainable manner. 
In this video, Sonali Fonseca,...
10/16/2020
Clinical Pathways
Conference Coverage
Clinical Pathways, Cancer Care and COVID-19
10/16/2020
Barry Russo, MBA, and Ray Page, DO, PhD, FACOI, FASCO, presented how their center has evolved to support patients during this time while still delivering high-value and high-quality clinical care.
Barry Russo, MBA, and Ray Page, DO, PhD, FACOI, FASCO, presented how their center has evolved to support patients during this time while still delivering high-value and high-quality clinical care.
Barry Russo, MBA, and Ray Page,...
10/16/2020
Clinical Pathways
Videos
OCPC 2020 Kicks Off Virtually
10/16/2020
The Oncology Clinical Pathways Congress, the official meeting of the Journal of Clinical Pathways, remains committed to being the only dedicated gathering for oncology pathways education.
The Oncology Clinical Pathways Congress, the official meeting of the Journal of Clinical Pathways, remains committed to being the only dedicated gathering for oncology pathways education.
The Oncology Clinical Pathways...
10/16/2020
Clinical Pathways
Conference Coverage
Oncology Clinical Pathways Benchmarking Survey 2020 Results
10/16/2020
In the opening session of the 5th annual Oncology Clinical Pathways Congress, Winston Wong, PharmD, editor-in-chief of the Journal of Clinical Pathways, presented a brief look at results from the Oncology Clinical Pathways Benchmarking Survey.
In the opening session of the 5th annual Oncology Clinical Pathways Congress, Winston Wong, PharmD, editor-in-chief of the Journal of Clinical Pathways, presented a brief look at results from the Oncology Clinical Pathways Benchmarking Survey.
In the opening session of the...
10/16/2020
Clinical Pathways
Videos
Practical Insights in Clinical Pathways, Now Virtual
07/24/2020
The Oncology Clinical Pathways Congress, the official meeting of the Journal of Clinical Pathways, remains committed to being the only dedicated gathering for oncology pathways education.
The Oncology Clinical Pathways Congress, the official meeting of the Journal of Clinical Pathways, remains committed to being the only dedicated gathering for oncology pathways education.
The Oncology Clinical Pathways...
07/24/2020
Clinical Pathways

About

As the official congress of the Journal of Clinical Pathways, this meeting serves as a forum for those involved in all stages of the pathway development to ask questions, learn how to measure outcomes, and explore ways to partner and expand pathway programs.

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use